Transplant of Epithelium Conjunctival Human Autologous Cultivated ex Vivo in Amniotic Membrane for the Treatment of Symblepharon

Inclusion Criteria: * Patients with ocular surface disorders, e.g. symblepharon * Indications for surgery will be the presence of ocular surface symptoms in the affected eye, loss of visual acuity from visual axis obscuration or irregular astigmatism, or cosmesis. * Only one eye of a patient will be eligible for study entry. * Patients who are adult males and females who are aged 16 or older, and are considered mentally sound * Patients who are willing to undergo long-term follow-up, as outlined in this protocol * Patients who have signed an informed consent form that has been approved by the SNEC Ethics Committee. Exclusion Criteria: * Patients less than 16 years of age * Patients who are incapable, either by law or of mental state, of giving consent in their own right * Patients who are either unable or unwilling to keep scheduled appointments and adhere to the other aspects of the protocol * Patients who are pregnant or breastfeeding * Patients with a history of drug allergy * Patients who have received an investigational drug within 28 days preceding surgery * Patients with intraocular pressure over 21 mmHg or history of ocular hypertension or glaucoma * Patients who are documented to be steroid responders